Loading...
N4 Pharma Plc
N4P.L•LSE
HealthcareDrug Manufacturers - Specialty & Generic
$0.47
$0.03(5.26%)
N4 Pharma Plc (N4P.L) Stock Overview
Explore N4 Pharma Plc’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for N4P.LStats details for N4P.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for N4P.LAnalyst Recommendations details for N4P.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
CEO
Mr. Nigel James Theobald
Employees
5
Headquarters
60 Gracechurch Street, London
Founded
1988